Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psychophysical endpoints.

C A Johnson1

  • 1Devers Eye Institute, Discoveries in Sight Research Labs, Portland, Oregon, USA.

European Journal of Ophthalmology
|May 7, 1999
PubMed
Summary
This summary is machine-generated.

Researchers need new ways to measure glaucoma treatment success beyond just eye pressure. This review explores advanced visual field tests and methods to better track disease progression and treatment effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular disease and differences between the sexes.

American family physician·2001
Same author

dSIR2 and dHDAC6: two novel, inhibitor-resistant deacetylases in Drosophila melanogaster.

Experimental cell research·2001
Same author

Frequency doubling perimetry using a liquid crystal display.

American journal of ophthalmology·2001
Same author

Operative management of neuromatous knee pain: patient selection and outcome.

Annals of plastic surgery·2001
Same author

Equal access to health care.

Canadian family physician Medecin de famille canadien·2001
Same author

Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis.

The Journal of biological chemistry·2001
Same journal

Long-term smoking and early-onset diabetic retinopathy in young-onset type 2 diabetes.

European journal of ophthalmology·2026
Same journal

Optimizing mitomycin C in photorefractive keratectomy: A paired-eye comparison of 15- versus 30-second applications.

European journal of ophthalmology·2026
Same journal

Honeycomb Keratopathy due to Rho-kinase inhibitor therapy.

European journal of ophthalmology·2026
Same journal

Mendelian randomisation in ophthalmology: An overview and practical guide for clinicians.

European journal of ophthalmology·2026
Same journal

Association of interleukin-6 pathway inhibition with risk of age-related macular degeneration: A propensity-matched cohort study.

European journal of ophthalmology·2026
Same journal

Clinical characteristics of thyroid eye disease with restrictive strabismus.

European journal of ophthalmology·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Medical Technology

Background:

  • Glaucoma management requires neuroprotective agents.
  • Demonstrating treatment efficacy beyond intraocular pressure (IOP) lowering is crucial.
  • Monitoring progressive glaucomatous loss presents significant challenges.

Purpose of the Study:

  • To review current techniques for assessing glaucoma progression.
  • To evaluate the advantages and disadvantages of various visual field analysis methods.
  • To discuss new perimetric tests and variability reduction strategies.

Main Methods:

  • Review of existing literature on visual field analysis.
  • Analysis of novel perimetric tests for glaucoma detection.
  • Examination of methods aimed at reducing measurement variability.

Related Experiment Videos

Main Results:

  • Current visual field analysis techniques have limitations.
  • Newer perimetric tests offer improved sensitivity but require further validation.
  • Methods to reduce variability are under development but not yet fully satisfactory.

Conclusions:

  • Effective glaucoma management necessitates outcome measures beyond IOP.
  • Advancements in visual field testing and variability reduction are critical for monitoring disease progression.
  • Further research is needed to establish definitive solutions for tracking treatment efficacy.